In the BioHarmony Drug Report Database
Gentamicin
Garamycin (gentamicin) is a small molecule pharmaceutical. Gentamicin was first approved as Garamycin on 1982-01-01. It is used to treat bacterial eye infections, bacterial infections, bacterial skin diseases, central nervous system infections, and endocarditis amongst others in the USA. It is known to target transient receptor potential cation channel subfamily A member 1.
Trade Name
|
Garamycin |
|---|---|
Common Name
|
gentamicin |
ChEMBL ID
|
CHEMBL3039597 |
Indication
|
bacterial eye infections, bacterial infections, bacterial skin diseases, central nervous system infections, endocarditis, escherichia coli infections, infectious bone diseases, klebsiella infections, proteus infections, pseudomonas infections, respiratory tract infections, serratia infections, soft tissue infections, staphylococcal infections, tuberculous peritonitis, urinary tract infections |
Drug Class
|
Antibiotics (Micromonospora strains) |
Image (chem structure or protein)